BALTIMORE, MD — Dr. Farzana Musawwir, PharmD, BCPS, Clinical Assistant Professor at the University of Maryland School of Pharmacy and Clinical Pharmacy Specialist in Transitional Care at the University of Maryland Medical Center (UMMC), was a featured speaker at the 19th Annual Nurse Practitioner & Physician Assistant Clinical Conference, themed “Taking Your Practice from Good to Great.”
Dr. Musawwir delivered two high-impact Continuing Medical Education (CME) sessions accredited through the American Academy of PAs (AAPA):
- Update on Diabetes Management 2026: Key therapeutic advancements, modern glycemic goals, cardio-renal protective pharmacotherapy, and strategies to improve patient adherence.
- COPD Update 2026: Current clinical guideline shifts, optimal inhaler selection, combination therapies, and evidence-based interventions to prevent hospital readmissions.
Both presentations earned excellent reviews from attending nurse practitioners and physician assistants for their clinical clarity, practical drug therapy insights, and immediate applicability to bedside and outpatient practice.
“Equipping advanced practice clinicians with practical, evidence-based pharmacotherapy updates directly translates to better long-term patient outcomes,” said Dr. Musawwir. “It was an honor to contribute to the clinical growth of our advanced practice community.”
- Speaker: Farzana Musawwir, PharmD, BCPS
- Affiliations: University of Maryland School of Pharmacy & UMMC Department of Pharmacy
- Event: 19th Annual Nurse Practitioner & Physician Assistant Clinical Conference
- Credits: AAPA Category 1 CME